Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Kinase inhibitors in thyroid cancers.
Sukrithan V, Jain P, Shah MH, Konda B. Sukrithan V, et al. Among authors: shah mh. Endocr Oncol. 2023 Jan 13;3(1):e220062. doi: 10.1530/EO-22-0062. eCollection 2023 Jan 1. Endocr Oncol. 2023. PMID: 37434642 Free PMC article. Review.
Favorable and Durable Response to Pazopanib in Metastatic Refractory Paraganglioma.
Patel S, Owen D, Schmidt CR, Kirschner LS, Phay J, Shirley L, Dillhoff M, Brock P, Espinosa A, Shah MH, Konda B. Patel S, et al. Among authors: shah mh. J Oncol Pract. 2017 Dec;13(12):840-842. doi: 10.1200/JOP.2017.024984. Epub 2017 Aug 29. J Oncol Pract. 2017. PMID: 28850312 No abstract available.
Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response.
Owen DH, Alexander AJ, Konda B, Wei L, Hemminger JA, Schmidt CR, Abdel-Misih SRZ, Dillhoff ME, Sipos JA, Kirschner LS, Shah MH. Owen DH, et al. Among authors: shah mh. Oncotarget. 2017 Oct 24;8(61):104046-104056. doi: 10.18632/oncotarget.22001. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262620 Free PMC article.
Targeting BRAF Mutations in High-Grade Neuroendocrine Carcinoma of the Colon.
Burkart J, Owen D, Shah MH, Abdel-Misih SRZ, Roychowdhury S, Wesolowski R, Haraldsdottir S, Reeser JW, Samorodnitsky E, Smith A, Konda B. Burkart J, et al. Among authors: shah mh. J Natl Compr Canc Netw. 2018 Sep;16(9):1035-1040. doi: 10.6004/jnccn.2018.7043. J Natl Compr Canc Netw. 2018. PMID: 30181415
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial.
Carneiro BA, Konda B, Costa RB, Costa RLB, Sagar V, Gursel DB, Kirschner LS, Chae YK, Abdulkadir SA, Rademaker A, Mahalingam D, Shah MH, Giles FJ. Carneiro BA, et al. Among authors: shah mh. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6193-6200. doi: 10.1210/jc.2019-00600. J Clin Endocrinol Metab. 2019. PMID: 31276163 Clinical Trial.
Metastatic Adrenocortical Carcinoma: a Single Institutional Experience.
Owen DH, Patel S, Wei L, Phay JE, Shirley LA, Kirschner LS, Schmidt C, Abdel-Misih S, Brock P, Shah MH, Konda B. Owen DH, et al. Among authors: shah mh. Horm Cancer. 2019 Dec;10(4-6):161-167. doi: 10.1007/s12672-019-00367-0. Epub 2019 Aug 29. Horm Cancer. 2019. PMID: 31468469 Free PMC article.
320 results